BackCrinetics Pharmaceuticals Overview
Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals PEG Ratio

Crinetics Pharmaceuticals (CRNX) has a PEG ratio of -50.61, below the Healthcare sector average of 11.64.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

-50.61

PEG Ratio

-50.61

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

Average PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Crinetics Pharmaceuticals (CRNX) FAQ

As of the most recent data, CRNX shows a PEG ratio of -50.61. That is below the Healthcare sector average of 11.64. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 11.64. Crinetics Pharmaceuticals is at -50.61, which is lower that average. That is roughly 534.8% below the sector mean. Use the comparison chart on this page to see how CRNX stacks up against individual peers as well.

Investors watch CRNX's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Crinetics Pharmaceuticals's latest reading is -50.61. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has Crinetics Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently -50.61) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 11.64, while CRNX is at -50.61. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.